Main Background

Viscoheal-Move without pain. Move with confidence

Viscoheal-Move without pain. Move with confidence

Viscoheal-Move without pain. Move with confidence

ViscoHeal™ is a sterile, single-use intra-articular injection containing sodium hyaluronate designed for patients with osteoarthritis (OA) of the knee who have failed conservative therapy.

ViscoHeal™ is a sterile, single-use intra-articular injection containing sodium hyaluronate designed for patients with osteoarthritis (OA) of the knee who have failed conservative therapy.

ViscoHeal™ is a sterile, single-use intra-articular injection containing sodium hyaluronate designed for patients with osteoarthritis (OA) of the knee who have failed conservative therapy.

Key Features

Key Features

Optimized Molecular Weight and Viscosity

Optimized Molecular Weight and Viscosity

Long-acting lubrication

Long-acting lubrication

100% biocompatible

100% biocompatible

Bioburden-free, sterile formulation

Bioburden-free, sterile formulation

European grade, GMP verified

European grade, GMP verified

ISO 13485 certified

ISO 13485 certified

Available in Two Strengths for One Standard of Care

Available in Two Strengths for One Standard of Care
Visual
Viscoheal

Ideal for routine OA knee management

Visual
Viscoheal

Ideal for routine OA knee management

Visual
Viscoheal plus

For advanced OA requiring extended lubrication

Visual
Viscoheal plus

For advanced OA requiring extended lubrication

Visual
Viscoheal

Ideal for routine OA knee management

Visual
Viscoheal plus

For advanced OA requiring extended lubrication

Clinical Evidence – Science that Matters

Clinical Evidence – Science that Matters

Clinical Evidence – Science that Matters
Pain & Function

WOMAC & VAS improvements confirm HA significantly reduces stiffness and improves mobility for up to 12 months

Pain & Function

WOMAC & VAS improvements confirm HA significantly reduces stiffness and improves mobility for up to 12 months

Cartilage Support

HA enhances chondrocyte activity and synovial fluid quality, protecting cartilage.

Cartilage Support

HA enhances chondrocyte activity and synovial fluid quality, protecting cartilage.

PRP + HA Synergy

Landmark trials show combination therapy improves cartilage thickness and extends clinical benefit beyond HA alone.

PRP + HA Synergy

Landmark trials show combination therapy improves cartilage thickness and extends clinical benefit beyond HA alone.

Safety Profile

Hyaluronic acid is biocompatible, non-immunogenic, and globally validated for osteoarthritis care.

Safety Profile

Hyaluronic acid is biocompatible, non-immunogenic, and globally validated for osteoarthritis care.

Clinical Benefits – Backed by Science

Clinical Benefits – Backed by Science

Provides long-lasting pain relief (6–12 months) in knee osteoarthritis patients unresponsive to conservative therapy.

Acts as a viscosupplement, restoring synovial fluid viscoelasticity

Anti-inflammatory action: downregulates IL-1β and TNF-α, easing synovial inflammation

Chondroprotective promise: preserves cartilage matrix and slows OA progression

Enhances mobility and quality of life without risks of long-term NSAIDs or steroids.

Competitive Edge – Not All HA Injections Are Equal

Feature / Benefit

ViscoHeal™

Generic HA Injections

Source & Grade

The total amount of cloud storage space allocated for your files.

European grade, GMP verified

Variable, inconsistent

Cross-Linking Options

The speed at which you can upload and download files to and from the cloud.

Available in 1% & 1.5% formulation

Usually single option

Cartilage Protection

The largest file size you can upload in a single action.

Supports chondrocytes, slows OA

Not consistently proven

PRP Synergy Evidence

The total amount of cloud storage space allocated for your files.

enhance cartilage repair

Rarely studied

Bioburden Testing

The speed at which you can upload and download files to and from the cloud.

Bioburden-free

Not guaranteed

Certification

The largest file size you can upload in a single action.

ISO 13485 , CDSCO compliant

Rare

Presentation

Manage access with a specified number of user accounts per plan.

Pre-filled syringe (ready-to-use)

Vials or ampoules

Potential Indication

  • Osteoarthritis
  • Chronic knee pain
  • Patients seeking non-invasive treatment.
  • Early-stage OA athletes
  • Cartilage degeneration
  • Combination therapy
Precision for Every Specialty
  • Osteoarthritis
  • Chronic knee pain
  • Patients seeking non-invasive treatment.
  • Early-stage OA athletes
  • Cartilage degeneration
  • Combination therapy

Answers to Common Questions

Answers to Common Questions

We’ve gathered the most frequently asked questions to help you better understand our AI services, pricing, and integration process.

We’ve gathered the most frequently asked questions to help you better understand our AI services, pricing, and integration process.

Support Avatar

Need more help?

We're here to answer any questions you may have.

Support Avatar

Need more help?

We're here to answer any questions you may have.

How long does pain relief last with ViscoHeal™?

How many injections are required?

How does ViscoHeal™ compare to oral painkillers or steroids?

Is ViscoHeal™ safe?

Who are the best candidates for ViscoHeal™? platelet dose affect outcomes?

How long does pain relief last with ViscoHeal™?

How many injections are required?

How does ViscoHeal™ compare to oral painkillers or steroids?

Is ViscoHeal™ safe?

Who are the best candidates for ViscoHeal™?

References

1. Altman RD, et al. Intra-articular hyaluronic acid: a review of efficacy and safety. BMC Musculoskeletal Disorders. 2015;16:321. – Demonstrated HA reduces pain and improves function in knee OA.

2. Ozturk A, et al. Comparison of intra-articular platelet-rich plasma and hyaluronic acid injections in knee osteoarthritis. Orthop Res Rev. 2018;10:13–20. – Showed PRP+HA combination therapy improves WOMAC and cartilage thickness vs HA alone.

3. Maheu E, et al. Intra-articular hyaluronic acid in knee osteoarthritis: an updated meta-analysis. Semin Arthritis Rheum. 2019;48(6):1236–1244. – Confirmed HA injections provide 6–12 months of pain relief and functional benefit.

4. Wang Y, et al. Viscosupplementation therapy for osteoarthritis: biological mechanisms and clinical evidence. Osteoarthritis Cartilage. 2020;28(4):455–470. – Describes HA’s chondroprotective and anti-inflammatory mechanisms.

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Cta Image
Cta Image

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Bring the Future of Regenerative Medicine to Your Patients — Today.

Request

a Demo

Cta Image
Cta Image